Agenda

8:00am – 12:00pm

Strategic Planning Committee meeting, Crystal

12:00pm – 1:00pm

Board of Directors lunch, Andiamo

1:00pm – 5:00pm

Board of Directors meeting, Crystal

Evening

Board of Directors dinner, STK The Landing: 1486 East Buena Vista Drive, Lake Buena Vista, FL 32830

8:30am – 12:30pm

Preconference Course: Introduction to Pharmacoepidemiology, Center
Speakers: Almut Winterstein, PhD, FISPE, University of Florida, Chintan Dave, PharmD, PhD, Rutgers University, Tobias Gerhard, PhD, FISPE, Rutgers University
This course will provide participants with a succinct introduction to the basic principles, concepts, and study designs of pharmacoepidemiology. The course includes lectures on (1) cohort studies, (2) case-control studies, as well as (3) confounding and other sources of bias.

Concurrent session:
Understanding Internal and External Validity in Drug Utilization Research: Selecting and Applying Appropriate Tools (Spanish-language session), Lanai
Speakers: Luciane Cruz Lopes, PhD, University of Sorocaba, Brazil, Maribel Salas, MD, MSc, DSc, FACP, FISPE, Bayer Inc., University of Pennsylvania
This session is designed for Spanish-speaking healthcare professionals, researchers, academicians, and policymakers involved or interested in drug utilization research. Whether you are a novice seeking an introduction to the field or an experienced professional aiming to enhance your critical appraisal skills, this session offers a discussion forum to better understand drug utilization and application in Latin American countries.

8:30am – 12:30pm

2024 Scientific Programme Committee meeting, Crystal

12:30pm – 1:30pm

Lunch, Center

1:30pm – 5:30pm

Preconference Course: Artificial Intelligence for Pharmacoepidemiology Research: An Introduction, Center
Speakers: Yu Huang, PhD, University of Florida, Aokun Chen, PhD, University of Florida, Serena Jingchuan Guo, MD, PhD, University of Florida, Tianze Jiao, PhD, University of Florida, Janick Weberpals, RPh, PhD, Harvard Medical School & Brigham and Women’s Hospital
Recent rapid advances in the field of artificial intelligence (AI) will dramatically change many fields, including pharmacoepidemiology. This course will give an overview of foundational principles and concepts in machine learning (ML), AI, and natural language processing (NLP), and introduce their practical/potential applications in pharmacoepidemiology research.

5:30pm – 7:00pm

Welcome reception, International Pool Deck at hotel

8:15am – 9:15am

Exhibits/Poster viewing, North

9:15am – 9:30am

Welcome/Opening Remarks, Center

• Lisa Pont, FISPE, ISPE President
• Almut Winterstein, FISPE, Chair, ISPE 2024 Mid-Year Scientific Program Committee
• Amie Goodin, Co-Chair, ISPE 2024 Mid-Year Scientific Program Committee

9:30am – 11:00am

Plenary Session I: Pharmacoepidemiology Meets AI, Center
Speakers: Yves A. Lussier, MD, Fellow ACMI, University of Utah, Jiang Bian, PhD, University of Florida, Rui Zhang, PhD, University of Minnesota, Nadea Leavitt, Senior Director, AI for Healthcare, IQVIA
Artificial intelligence plays a crucial role in strengthening health systems and patient care. In the pharmacoepidemiology field, AI can utilize big data to assess the use, benefits, and risks of drugs already in use among different patient populations. This panel will bring experts from both academia and industry together to provide insights on the role of AI in real-world drug evaluations.

11:00am – 11:30am

Coffee break/Exhibits/Poster viewing, North Foyer

11:30am – 1:00pm

Plenary Session II: Pharmacoepidemiology Meets Pharmacology: The Value of Triangulation, Center
Speakers: Patrick Antonelli, MD, MS, University of Florida, Antonios Douros, Associate Professor, Dr. med., Institute of Clinical Pharmacology and Toxicology Charité – Universitätsmedizin Berlin, Brian Cicali, PharmD, PhD, University of Florida, Janick Weberpals, RPh, PhD, Harvard Medical School & Brigham and Women’s Hospital
This plenary session will showcase translational collaborations between pharmacoepidemiology and pharmacology. Faculty in pharmacology and pharmacoepidemiology will describe how parallel work streams are used to inform and validate each other’s approaches, with the goal to accelerate evidence generation.

1:00pm – 2:00pm

Lunch, North

2:00pm – 3:30pm

Student Oral Session I, Center

3:30pm – 4:00pm

Coffee break/Exhibits/Poster viewing, North Foyer

4:00pm – 5:30pm

Student Oral Session II, Center

6:00pm – 7:00pm

Student meet-and-greet, City Works Restaurant at Disney Springs

7:30am – 8:45am

Exhibits/Poster viewing, North

8:45am – 10:15am

Plenary Session III: Pharmacoepidemiology Meets Policy, Center
Speakers: Amir Sarayani, PhD, PharmD, MPH, Johnson & Johnson, Inmaculada Hernandez, PharmD, PhD, University of California, San Diego, Jeff Talbert, PhD, University of Kentucky College of Pharmacy, Gita Toyserkani, PharmD, MBA, US Food and Drug Administration
This plenary session will highlight examples of research at the intersection of pharmacoepidemiology and policy. Panelists will describe how pharmacoepidemiology research has been applied within policy evaluations and describe opportunities for pharmacoepidemiology research to inform policy change.

10:15am – 11:00am

Coffee break/Exhibits/Poster viewing, North Foyer

11:00am – 12:30pm

Plenary Session IV: Pharmacoepidemiology Meets Environmental Epi and Climate Change, Center
Speakers: Soko Setoguchi, MD, DrPH, FISPE, Rutgers Robert Wood Johnson Medical School, Benjamin Bates, MD, Rutgers Robert Wood Johnson Medical School, Paul Coplan, MBA, ScD, FISPE, University of Pennsylvania School of Medicine, Jennifer Lund, PhD, FISPE, UNC Gillings School of Global Public Health
Climate changes can alter the effects of medications, access to medications, and approaches to minimizing pharmaceutical waste. This session will cover these topics and raise challenge that we face now and in the future.

12:30pm – 12:45pm

Closing remarks/Adjournment, Center

• Amie Goodin, Co-Chair, ISPE 2024 Mid-Year Scientific Program Committee
• Liz Mansi, Chair, ISPE Student Council